Richard Newitter

Stock Analyst at Truist Securities

(2.21)
# 1014
Out of 5,376 analysts
428
Total ratings
Success rate
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
TNDM Tandem Diabetes Care
Initiates Coverage On: Hold
24
20.23 18.64% 1 Jun 16, 2025
DXCM DexCom
Initiates Coverage On: Buy
102
80.04 27.44% 1 Jun 16, 2025
PODD Insulet
Initiates Coverage On: Buy
365
303.25 20.36% 1 Jun 16, 2025
BBNX Beta Bionics
Initiates Coverage On: Buy
26
17.89 45.33% 1 Jun 16, 2025
GMED Globus Medical
Maintains: Hold
80 68
57.82 17.61% 27 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
127 117
79.23 47.67% 18 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
140 137
117.98 16.12% 37 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
390 400
375.41 6.55% 19 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
140 135
100.31 34.58% 5 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
140 150
117.92 27.2% 7 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
113 117
101.37 15.42% 12 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
605 590
509.38 15.83% 28 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 70
60.26 16.16% 14 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
61 51
41.99 21.46% 3 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
10 8
5.53 44.67% 14 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 90
86.29 4.3% 15 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 24
20.3 18.23% 10 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 19
11.64 63.23% 18 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
78 75
73.78 1.65% 18 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
111 145
145.61 -0.42% 16 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
250 235
130.8 79.66% 24 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
118 113
91.2 23.9% 32 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
240 285
256.73 11.01% 5 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
7 5
n/a n/a 11 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 63
n/a n/a 15 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
48 51
n/a n/a 7 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 21
16.39 28.13% 1 Jan 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
12 7
n/a n/a 3 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 80
n/a n/a 3 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
30 31
n/a n/a 3 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
13.64 46.63% 1 Aug 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
71 82
85.5 -4.09% 5 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
29
n/a n/a 11 Aug 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
260 250
168.59 48.29% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 110
n/a n/a 5 May 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 26
3.23 704.95% 4 May 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
690 770
181.72 323.73% 10 Apr 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
94 85
64.5 31.78% 6 Apr 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
12.45 60.64% 1 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
23 27
9.72 177.78% 5 Feb 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 32
n/a n/a 6 Jun 21, 2018